This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Neurology
Neurology
Memantine ‘not effective’ for Down’s dementia prevention
Interferon-b: first-line therapy in multiple sclerosis
FDA approves Onfi™ for Lennox-Gastaut
AFFiRiS awarded $1.5m for ‘first Parkinson’s vaccine’
Swissmedic accept epilepsy drug perampanel for review
Merck KGaA acquires multiple sclerosis drug
IEC: ‘Zebinix® can replace standard monotherapy’
IEC: ‘Perampanel significantly reduces seizure frequency’
IEC: Zonisamide proves comparable to carbamazepine
IEC: ‘Zonegran effective and well-tolerated in children’
IEC: Zonegran results presented at Epilepsy Congress
Multiple sclerosis: Recent treatment advances
« Previous
1
…
11
12
13
14
15
…
36
Next »
Most read
1
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: